🔎 Trials Near Me

Hem › Melanom › Illinois

Kliniska studier för Melanom i Illinois

22 studier för Melanom söker deltagare vid platser i Illinois.

Städer i Illinois

Officiell studietext (engelska)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • OSF Saint Anthony's Health Center, Alton
  • Rush-Copley Medical Center, Aurora
  • Advocate Outpatient Center - Aurora, Aurora
  • och 54 fler
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 40 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • University of Illinois Cancer Center, Chicago
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT06172478

DESTINY-PANTUMOUR04

  • Research Site, Decatur
RekryterarObservationsstudie
Ålder 18 till 130 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07124000

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

  • Rush-Copley Medical Center, Aurora
  • Illinois CancerCare-Bloomington, Bloomington
  • Illinois CancerCare-Canton, Canton
  • och 38 fler
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT05136196

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

  • Hope and Healing Cancer Services, Hinsdale
  • Advocate Lutheran General Hospital, Park Ridge
  • Illinois CancerCare, Peoria
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06246916

Pan-tumor MRD Study

  • Cancer Care Specialists of Illinois (CCSI), O'Fallon
  • Carle Health, Urbana
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT06605404

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

  • Loyola Center for Health at Burr Ridge, Burr Ridge
  • Northwestern University, Chicago
  • Swedish Covenant Hospital, Chicago
  • och 8 fler
RekryterarFas 3
Ålder 75 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT07068074

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • Saint Anthony's Health, Alton
  • Rush - Copley Medical Center, Aurora
  • Illinois CancerCare-Bloomington, Bloomington
  • och 33 fler
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 15 sep. 2026 · NCT04511013

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

  • Northwestern University, Chicago
  • Memorial Hospital East, Shiloh
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 31 aug. 2026 · NCT05896839

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Lurie Children's Hospital-Chicago, Chicago
RekryterarFas 1/2
12 Months – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT04851119

Project: Every Child for Younger Patients With Cancer

  • Rush-Copley Medical Center, Aurora
  • Lurie Children's Hospital-Chicago, Chicago
  • Northwestern University, Chicago
  • och 16 fler
RekryterarObservationsstudie
Upp till ålder 25 · Alla kön · Uppdaterad 25 aug. 2026 · NCT02402244

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • Orchard Healthcare Research Inc, Skokie
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 5 aug. 2026 · NCT06330064

Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions

  • Northwestern University, Chicago
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 10 juli 2026 · NCT07556380

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

  • Call for Information (Investigational Site 0024), Chicago
RekryterarFas 1/2
6 Months – 17 Years · Alla kön · Uppdaterad 6 juli 2026 · NCT02332668

Integrated Cancer Repository for Cancer Research

  • Rush-Copley Cancer Care Center, Aurora
  • Rush-Copley Healthcare Center, Yorkville
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 19 till 110 · Alla kön · Uppdaterad 29 juni 2026 · NCT02012699

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

  • University of Chicago Medical Center, Chicago
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 13 maj 2026 · NCT03686124

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

  • Northwestern Memorial Hospital, Chicago
  • University of Chicago Medical Center, Chicago
RekryterarFas 2/3
Alla åldrar · Alla kön · Uppdaterad 2 apr. 2026 · NCT06581406

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • OSF Saint Anthony's Health Center, Alton
  • Rush-Copley Medical Center, Aurora
  • Advocate Outpatient Center - Aurora, Aurora
  • och 45 fler
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 17 mars 2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Chicago
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

  • Advocate Illinois Masonic Medical Center, Chicago
  • Northwestern Medicine Cancer Center Kishwaukee, DeKalb
  • Northwestern University, Evanston
  • och 4 fler
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 27 nov. 2024 · NCT03860883

Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

  • Loyola University Medical Center, Maywood
RekryterarFas 1
Ålder 18 till 89 · Alla kön · Uppdaterad 12 mars 2018 · NCT02870244

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.